{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:41:58Z","timestamp":1775043718075,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1454,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Few data exist on the prevalence of hyperprolactinaemia in the community. This study was intended to determine the prevalence of hyperprolactinaemia in a sample closely matched to the current British population aged 38 years and over.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN AND PATIENTS<\/jats:title><jats:p>The 1877 survivors at the 20\u2010year follow\u2010up of the Whickham Survey were a cross\u2010sectional sample of the community aged 38 years and over. Serum was frozen and stored at \u221230\u00b0C from 90% of the survivors (751 men, 924 women, median age 58 years (range 38 to 93 years)) who participated in the follow\u2010up survey.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>Two years after the follow\u2010up survey, serum prolactin concentrations were measured by ELISA\/1 step sandwich assay (reference range \u2264\u2003600\u2003mU\/l in men and women). A repeat prolactin measurement was made in those subjects who had prolactin levels within the top 2.5% of men and women in this sample.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>At screening, 0.7% of the men and 2.5% of the women had serum prolactin levels greater than 600\u2003mU\/l. For men, 2.5% were above 400\u2003mU\/l. The prevalence of hyperprolactinaemia, if defined as greater than 400\u2003mU\/l in men and greater than 600\u2003mU\/l in women on repeat testing, was 1.4% in the men and 1.2% in the women. The aetiology in men was prolactin\u2010raising drugs (<jats:italic>n<\/jats:italic>\u2003=\u20033), renal failure (<jats:italic>n<\/jats:italic>\u2003=\u20031), microprolactinoma (<jats:italic>n<\/jats:italic>\u2003=\u20031), and unknown (<jats:italic>n<\/jats:italic>\u2003=\u20032), and in women it was prolactin\u2010raising drugs (<jats:italic>n<\/jats:italic>\u2003=\u20037), microprolactinoma (<jats:italic>n<\/jats:italic>\u2003=\u20031), and unknown (<jats:italic>n<\/jats:italic>\u2003=\u20031). Logarithmic transformation of serum prolactin concentrations produced Gaussian distributions with 95% reference ranges of 60\u2013430\u2003mU\/l in men and 40\u2013560\u2003mU\/l in women. No significant relationship was found in either sex between hyperprolactinaemia and age or evidence of autoimmune thyroid disease at either survey. In women, there was no association with age, distance beyond the menopause or duration of reproductive years but prolactin levels were slightly higher in those on oestrogen therapy (geometric mean prolactin 226\u2003mU\/l compared to 178\u2003mU\/l; <jats:italic>t<\/jats:italic>\u2010test on log prolactin <jats:italic>t<\/jats:italic>\u2003=\u20033.79; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>This study has demonstrated that a gender\u2010related reference range for serum prolactin is necessary. Pituitary pathology is not common and screening with measurement of serum prolactin is not warranted in middle\u2010aged and elderly subjects. In asymptomatic subjects with modestly elevated serum prolactin levels (&lt;\u20033 SD above the mean), extensive pituitary imaging and investigation is unwarranted. Autoimmune thyroid disease was not a significant cause of hyperprolactinaemia in this sample.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00343.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:35:20Z","timestamp":1047378920000},"page":"39-44","source":"Crossref","is-referenced-by-count":44,"title":["The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort"],"prefix":"10.1111","volume":"48","author":[{"family":"Vanderpump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Appleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Tunbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kendall\u2010Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1002","article-title":"Hyperprolactinaemia: when is a prolactinoma not a prolactinoma?","author":"Anonymous","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90373-1"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0889-8529(18)30234-2","article-title":"Hyperprolactinaemia. Evaluation and management","volume":"21","author":"Blackwell R.E.","year":"1992","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb01661.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198101153040306"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00299.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92112-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456328602300603"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.00824.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb02997.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-5-855"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb03608.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349060"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb00218.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0740255"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0015-0282(16)55139-5","article-title":"Clinical history and outcome of 59 patients with idiopathic hyperprolactinemia","volume":"58","author":"Sluijmer A.V.","year":"1992","journal-title":"Fertility and Sterility"},{"key":"e_1_2_6_18_2","unstructured":"Snyder P.J.(1996) The pituitary in hypothyroidism. InWerner and Ingbar's The Thyroid: A Fundamental and Clinical Text 7th edn (eds L.E. Braverman & R.D. Utiger) pp.836840. J.B. Lippencott\u2013Raven Philadelphia New York."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6876.507"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb01155.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1973.tb00430.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01340.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"e_1_2_6_24_2","first-page":"155","article-title":"The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20\u2010year follow\u2010up study of an English community","volume":"6","author":"Vanderpump M.P.J.","year":"1996","journal-title":"Thyroid"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1984.61.5.0814"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00343.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00343.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00343.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:59:27Z","timestamp":1698454767000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00343.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00343.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00343.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}